首页 | 本学科首页   官方微博 | 高级检索  
     

胰岛素联合沙格列汀降糖疗效及安全性的研究
引用本文:吕凌波,简玉香,陈苑波. 胰岛素联合沙格列汀降糖疗效及安全性的研究[J]. 广东微量元素科学, 2017, 24(5). DOI: 10.3969/j.issn.1006-446X.2017.05.006
作者姓名:吕凌波  简玉香  陈苑波
作者单位:深圳市第二人民医院,广东 深圳,518000
基金项目:201506020深圳市卫人委
摘    要:目的评估胰岛素联合沙格列汀治疗2型糖尿病的有效性和安全性。方法回顾性对照研究50例2型糖尿病患者胰岛素加用沙格列汀或阿卡波糖治疗(48±8)周后血糖水平和血糖波动等指标的变化。结果治疗(48±8)周后,两组血糖、Hb A1c、MAGE均明显下降(P均≤0.001),其中沙格列汀组MAGE的降幅明显大于阿卡波糖组(P=0.024),胃肠道不良反应发生率显著低于阿卡波糖组。结论沙格列汀联合胰岛素具有更强的控制血糖波动的疗效,胃肠道不良反应发生率更低。

关 键 词:2型糖尿病  沙格列汀  阿卡波糖  血糖波动

Study on Hypoglycemic Effect and Safety of Insulin Combined with Shah Glenn Dean
LU Lingbo,JIAN Yuxiang,CHEN Yuanbo. Study on Hypoglycemic Effect and Safety of Insulin Combined with Shah Glenn Dean[J]. Trace Elements Science, 2017, 24(5). DOI: 10.3969/j.issn.1006-446X.2017.05.006
Authors:LU Lingbo  JIAN Yuxiang  CHEN Yuanbo
Abstract:Objective To assess the efficacy and safety of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes(T2DM) on basic of insulin.Methods 50 patients with poorly controlled T2DM on basic of insulin were added on saxagliptin or acarbose for (48±8) weeks.Retrospective control studies change of plasma glucose,HbA1c,MAGE and so on.Results After treatment for (48±8) weeks,the plasma glucose,HbA1c and MAGE decreased significantly in both groups(all P≤0.001).It shows more remarkable decrease in MAGE and less gastrointestinal symptoms in saxagliptin group than those of acarbose group(P=0.024).Conclusion Saxagliptin-insulin has similar effect on glucose control with acarbose-insulin in patients with T2DM,and more improvement in glucose fluctuations and lower gastrointestinal side effects than the latter.
Keywords:type 2 diabetes mellitus  saxagliptin  acarbose  glucose fluctuations
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号